×
About 798 results

ALLMedicine™ Anaplastic Thyroid Cancer Center

Research & Reviews  296 results

Inactivation of PDH can Reduce Anaplastic Thyroid Cancer Cells' Sensitivity to Artemisi...
https://doi.org/10.2174/1871520621666210910100803
Anti-cancer Agents in Medicinal Chemistry; Li Y

Sep 14th, 2021 - Anaplastic thyroid cancer (ATC) is a rare subtype of thyroid tumors with a high mortality rate. Targeted therapies against ATC are ineffective and mostly transient. Artemisinin has shown excellent anti-tumor activity in several cancers, but its ef...

Response to immunotherapy in a patient with anaplastic thyroid cancer: A case report.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360478
Medicine Zheng L, Li L et. al.

Aug 17th, 2021 - Anaplastic thyroid carcinoma (ATC) is an aggressive malignancy that is almost always fatal and lacks effective systemic treatment options. Current treatments of ATC include surgery, radiation, and chemotherapy, used in combination when possible. I...

Glycolytic inhibition with 3-bromopyruvate suppresses tumor growth and improves surviva...
https://doi.org/10.1016/j.surg.2021.05.055
Surgery Zhao B, Aggarwal A et. al.

Aug 3rd, 2021 - Anaplastic thyroid cancer is a rare but devastating malignancy. Anaplastic thyroid cancer cells exhibit the Warburg effect by preferentially undergoing glycolysis even in aerobic conditions, leading to high glucose use. Here we assess if targeted ...

Inhibition of IRAK1/4 enhances the antitumor effect of lenvatinib in anaplastic thyroid...
https://doi.org/10.1111/cas.15095
Cancer Science; Kawamura Y, Saijo K et. al.

Jul 31st, 2021 - Anaplastic thyroid cancer (ATC) is an extremely aggressive tumor associated with poor prognosis due to a lack of efficient therapies. In Japan, lenvatinib is the only drug approved for patients with ATC; however, its efficacy is limited. Therefore...

see more →

Guidelines  1 results

Anaplastic Thyroid Carcinoma, Version 2.2015.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986600
Journal of the National Comprehensive Cancer Network : JN... Haddad RI, Lydiatt WM et. al.

Sep 12th, 2015 - This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosage...

see more →

News  22 results

Targeted Treatment Tied to Longer Survival in Patients With Anaplastic Thyroid Cancer
https://www.medscape.com/viewarticle/936044

Aug 21st, 2020 - NEW YORK (Reuters Health) - With the introduction of targeted treatments for anaplastic thyroid carcinoma, patients have seen significant improvements in survival, according to a new report. "Over the last 5 years, a greater understanding of the m...

Targeted Treatment Tied to Longer Survival in Patients With Anaplastic Thyroid Cancer
https://www.staging.medscape.com/viewarticle/936044

Aug 21st, 2020 - NEW YORK (Reuters Health) - With the introduction of targeted treatments for anaplastic thyroid carcinoma, patients have seen significant improvements in survival, according to a new report. "Over the last 5 years, a greater understanding of the m...

My Strangest Case: The Man With a Heavy Tongue
https://reference.medscape.com/viewarticle/934944_3

Aug 4th, 2020 - Discussion Four aspects make this case unusual. First, the length of time between the diagnosis and relapse, 40 years, was remarkable. Ordinarily, the prognosis for the patient's original tumor type, follicular thyroid cancer, is excellent; howeve...

Endocrinologists Navigate Deferments, Telehealth Amid COVID-19
https://www.medscape.com/viewarticle/930116

May 7th, 2020 - Editor's note: Find the latest COVID-19 news and guidance in Medscape's  Coronavirus Resource Center. James V. Hennessey, MD, has been working from home, like so many others, since the lockdowns went into effect. The director of clinical endocrino...

Multimodal therapies almost double survival in anaplastic thyroid cancer
https://www.mdedge.com/endocrinology/article/212736/pituitary-thyroid-adrenal-disorders/multimodal-therapies-almost-double?channel=53
Kari Oakes

Nov 20th, 2019 - CHICAGO – Overall survival for patients with anaplastic thyroid cancer was boosted when their care facilitated a rapid work-up, comprehensive treatment planning, and integrated implementation of multimodal therapies. Median survival for participan.

see more →